These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11136323)

  • 1. Detection, treatment and outcome of axillary recurrence after axillary clearance for invasive breast cancer.
    de Boer R; Hillen HF; Roumen RM; Rutten HJ; van der Sangen MJ; Voogd AC
    Br J Surg; 2001 Jan; 88(1):118-22. PubMed ID: 11136323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term prognosis of patients with axillary recurrence after axillary dissection for invasive breast cancer.
    Voogd AC; Cranenbroek S; de Boer R; Roumen RM; Rutten HJ; van der Sangen MJ
    Eur J Surg Oncol; 2005 Jun; 31(5):485-9. PubMed ID: 15922883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consequences of axillary recurrence after conservative breast surgery.
    Fredriksson I; Liljegren G; Arnesson LG; Emdin SO; Palm-Sjövall M; Fornander T; Holmqvist M; Holmberg L; Frisell J
    Br J Surg; 2002 Jul; 89(7):902-8. PubMed ID: 12081741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection, treatment, and outcome of isolated supraclavicular recurrence in 42 patients with invasive breast carcinoma.
    van der Sangen MJ; Coebergh JW; Roumen RM; Rutten HJ; Vreugdenhil G; Voogd AC
    Cancer; 2003 Jul; 98(1):11-7. PubMed ID: 12833449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of axillary recurrence after axillary lymph node dissection for invasive breast cancer.
    Voogd AC; de Boer R; van der Sangen MJ; Roumen RM; Rutten HJ; Coebergh JW
    Eur J Surg Oncol; 2001 Apr; 27(3):250-5. PubMed ID: 11373100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management and outcomes of isolated axillary node recurrence in breast cancer.
    Konkin DE; Tyldesley S; Kennecke H; Speers CH; Olivotto IA; Davis N
    Arch Surg; 2006 Sep; 141(9):867-72; discussion 872-4. PubMed ID: 16983030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
    Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
    Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of the axilla in operable breast cancer treated by breast conservation: a randomized clinical trial. Edinburgh Breast Unit.
    Chetty U; Jack W; Prescott RJ; Tyler C; Rodger A
    Br J Surg; 2000 Feb; 87(2):163-9. PubMed ID: 10671921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact on regional recurrence and survival of axillary surgery in women with node-negative primary breast cancer.
    Axelsson CK; Düring M; Christiansen PM; Wamberg PA; Søe KL; Møller S;
    Br J Surg; 2009 Jan; 96(1):40-6. PubMed ID: 19108002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional nodal recurrence in the management of breast cancer patients with one to three positive axillary lymph nodes. Outcome of patients following tangential irradiation without a separate nodal field.
    Stranzl H; Peintinger F; Ofner P; Prettenhofer U; Mayer R; Hackl A
    Strahlenther Onkol; 2004 Oct; 180(10):623-8. PubMed ID: 15480510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years.
    Domènech A; Benitez A; Bajén MT; Pla MJ; Gil M; Martín-Comín J
    Oncology; 2007; 72(1-2):27-32. PubMed ID: 17998787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
    Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
    J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
    Bulte CS; van der Heiden-van der Loo M; Hennipman A
    Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axillary regional recurrence after sentinel lymph node biopsy for breast cancer.
    Rosing DK; Dauphine CE; Vargas MP; Gonzalez K; Burla M; Kaufmann P; Vargas HI
    Am Surg; 2006 Oct; 72(10):939-42. PubMed ID: 17058740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast-conserving treatment of early breast cancer: survival and recurrence in community hospitals in southeastern Netherlands.
    Voogd AC; Coebergh JW; Crommelin MA; van der Heyden LH; Kluck HM
    Neth J Surg; 1991 Aug; 43(4):105-9. PubMed ID: 1944987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients.
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1062-73. PubMed ID: 15234040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up.
    Louis-Sylvestre C; Clough K; Asselain B; Vilcoq JR; Salmon RJ; Campana F; Fourquet A
    J Clin Oncol; 2004 Jan; 22(1):97-101. PubMed ID: 14701770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection.
    Roumen RM; Kuijt GP; Liem IH; van Beek MW
    Br J Surg; 2001 Dec; 88(12):1639-43. PubMed ID: 11736979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.